SERPINB1 and neoplasm: In conclusion, patients showing strong SERPINB1 protein expression in tumor tissue are likely to benefit from cisplatin-containing chemotherapy regimens; vice versa, a low tissue protein expression of this marker would suggest the corresponding patient to be spared a cisplatin-based chemotherapy due to the low probability of response.